About

About HoHo Biotech Co., LTD HOHO Biotech is a Taiwan-based biotech company specializing in molecular hydrogen therapy as a clinically proven adjuvant for managing Autoimmune diseases, chronic Inflammation, and Cancer. Its flagship products include hydrogen capsules and H₂/O₂ inhalation devices, used in hospitals, clinics, and pharmacies. Backed by clinical trials and publications, HOHO Biotech offers a natural antioxidant and anti-inflammatory capsule that enhances drug efficacy and reduces side effects. Partnering with major medical centers, HOHO Biotech leads the field in hydrogen medicine, aiming for global expansion through research, regulatory approval, and partnerships. Search “HOHO Biotech hydrogen therapy” or visit www.hoholab.com.tw to learn more. HOHO Biotech LinkedIn: www.linkedin.com/company/hoho-biotech Benson LinkedIn: https://www.linkedin.com/in/kuang-yih-wang-ab14b621/ https://www.hohobio.com Website Taiwan: https://www.hoholab.com.tw/ Phone: +886920757313 Email: Benson@hohobio.com Industry Hospitals and Health Care Company size 2-10 employees 2 associated members LinkedIn members who’ve listed HOHO Biotech as their current workplace on their profile. Founded 1976 Specialties molecular hydrogen therapy, hydrogen capsules, anti-inflammatory capsule, autoimmune disease adjuvant, natural antioxidant supplement, hydrogen medicine Taiwan, H₂/O₂ inhalation device, clinical trial hydrogen therapy, reduce drug side effects, and HOHO Biotech Taiwan HoHo Biotech was founded in 2017. The company focuses on Autoimmune Disease, Hydrogen-Based Molecular Medicine, and gut microenvironment research. In 2018, it developed a "Hydrogen Capsule", a proprietary natural coral calcium material. In 2020, it received TFDA approval, becoming a "Prescription use in Regional Hospital", based on clinical trial data. In 2022, it became a "Prescription Use in Medical Center". In 2024, Launched H2 Capsule in "Pharmacy Chains", more than 200 shops. In 2024, HoHo introduced an AI molecular simulation system and built the Molecular Intelligence Engine, combining functional material science with computational modeling. In 2025, published more than 18+ Medical Papers as evidence of the "Hydrogen Capsule" as a perfect "Adjuvant" in the Autoimmune area. Launched HydroChat, an AI assistant for personalized applications. This development led to the company’s core strategy, Gut Engineering, which uses molecular signals to regulate the intestinal environment.